Details of the Drug Inactive Ingredient (DIG)
General Information of DIG (ID: E0X2OX) | |||||
---|---|---|---|---|---|
DIG Name |
Medium-chain triglyceride
|
||||
DIG Function |
Emollient; Lubricant; Surfactant
|
||||
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Raltegravir
|
API Info |
Human immunodeficiency virus infection [ICD-11: 1C60]
|
[1] | |||
ICD Disease Classification 04 | Immune system disease | Click to Show/Hide | ||||
Cetirizine
|
API Info |
Allergy [ICD-11: 4A80]
|
[2] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Paricalcitol
|
API Info |
Hyperparathyroidism [ICD-11: 5A51]
|
[3] | |||
Ergocalciferol
|
API Info |
Hypoparathyroidism [ICD-11: 5A50]
|
[4] | |||
Doxercalciferol
|
API Info |
Hyperparathyroidism [ICD-11: 5A51]
|
[5] | |||
Calcifediol
|
API Info |
Vitamin deficiency [ICD-11: 5B55]
|
[6] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Venlafaxine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[7] | |||
Methylphenidate
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[8] | |||
Guanfacine
|
API Info |
Attention deficit hyperactivity disorder [ICD-11: 6A05]
|
[9] | |||
ICD Disease Classification 07 | Sleep-wake disorder | Click to Show/Hide | ||||
Dextroamphetamine
|
API Info |
Narcolepsy [ICD-11: 7A20]
|
[10] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Acetaminophen
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[11] | |||
Levetiracetam
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[12] | |||
Carbamazepine
|
API Info |
Epilepsy [ICD-11: 8A60]
|
[13] | |||
Topiramate
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[14] | |||
ICD Disease Classification 09 | Visual system disease | Click to Show/Hide | ||||
Dextromethorphan
|
API Info |
Allergic conjunctivitis [ICD-11: 9A60]
|
[15] | |||
Acetazolamide
|
API Info |
Glaucoma [ICD-11: 9C61]
|
[16] | |||
ICD Disease Classification 10 | Ear/mastoid process disease | Click to Show/Hide | ||||
Diphenhydramine
|
API Info |
Meniere disease [ICD-11: AB31]
|
[17] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Nimodipine
|
API Info |
Cerebral vasospasm [ICD-11: BA85]
|
[18] | |||
ICD Disease Classification 12 | Respiratory system disease | Click to Show/Hide | ||||
Benzonatate
|
API Info |
Asthma [ICD-11: CA23]
|
[19] | |||
ICD Disease Classification 13 | Digestive system disease | Click to Show/Hide | ||||
Simethicone
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[20] | |||
Rabeprazole
|
API Info |
Gastro-oesophageal reflux disease [ICD-11: DA22]
|
[21] | |||
Ursodeoxycholic acid
|
API Info |
Hepatic fibrosis/cirrhosis [ICD-11: DB93]
|
[22] | |||
Lubiprostone
|
API Info |
Irritable bowel syndrome [ICD-11: DD91]
|
[23] | |||
Rolapitant
|
API Info |
Functional nausea/vomiting [ICD-11: DD90]
|
[24] | |||
ICD Disease Classification 14 | Skin disease | Click to Show/Hide | ||||
Isotretinoin
|
API Info |
Acne vulgaris [ICD-11: ED80]
|
[25] | |||
Tretinoin
|
API Info |
Acne vulgaris [ICD-11: ED80]
|
[26] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Cyclosporin A
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[27] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Ibuprofen
|
API Info |
Dysmenorrhea [ICD-11: GA34]
|
[28] | |||
Tolterodine
|
API Info |
Overactive bladder [ICD-11: GC50]
|
[29] | |||
Dutasteride
|
API Info |
Prostatic hyperplasia [ICD-11: GA90]
|
[30] | |||
ICD Disease Classification 20 | Developmental anomaly | Click to Show/Hide | ||||
Calcitriol
|
API Info |
Congenital alopecia [ICD-11: LC30]
|
[31] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Cell line (CELL) | ||||||
DBT Name: Colon cancer Caco-2 cells (Caco-2) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Inhibition ratio > 36 % (tested by experiment) | [32] | ||||
Tested Species | Homo sapiens (Human) | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.